Study design and setting
Cancer
CANCER
This study was a mixed-methods, cluster randomised controlled trial (CRCT) which was conducted from January 2017 to December 2020. Cancer services in New South Wales (NSW), Australia’s most populous state, were invited to participate in the study. Participating services were randomised to a Core versus Enhanced implementation strategy to promote uptake of and adherence to the ADAPT CP. Randomisation was stratified by size of service (large (≥ 100 new pts./year) versus small (< 100 new pts./year)) to ensure approximately equal patient volume in the two study arms.